Explorer les evidences

Palier Gold : evidences validées mécaniquement, avec leur source primaire.

1 754 evidences · page 56 / 71

50 %Bioefficacy evaluation of long-lasting insecticidal nets (LLINs) revealed low mosquito mortality rates of 50% for LLINs collected in both sites when tested against field An. gambiae (s.s) and An. coluzzii mosquito populations.

CamerounAn. coluzzii · An. gambiae (s.s) · paludismeHAL · Unilimdocument de 89 observations

22,5 %Hyperprolactinemia is responsible for 20 to 25% of consultations of secondary amenorrhea.

Camerounhyperprolactinemiapublié 2020The Pan African medical journaleurope_pmcdocument de 4 observations

80 patientsIn the study conducted at the Pediatric Endocrinology Unit of the Mother and Child Centre of the Chantal Biya Foundation in Yaounde, Cameroon from May 2013 to December 2019, 80 patients were diagnosed with Disorders of Sex Development (DSD).

CamerounDisorders of Sex Development (DSD)observé May 2013 to December 2019publié 2020Journal of pediatric endocrinology & metabolism : JPEMeurope_pmcdocument de 4 observations

Metabolic syndrome was defined using the Joint Interim Statement 2009 criteria.

Camerounsyndrome métaboliqueobservé 2009publié 2014Annales d'endocrinologieeurope_pmcdocument de 3 observations

10,4 %Among hypertensive participants in Cameroon, 10.4% [95% CI 7.5–13.3] had controlled hypertension during 2011–2018.

Camerounhypertension artérielleobservé 2011-2018publié 2019Journal of hypertensioneurope_pmcdocument de 20 observationsDOI 10.1097/hjh.0000000000002165

75,2 %Gram-negative bacteria accounted for 75.2% of isolated germs.

Camerounpied diabétiquepublié 2022The Pan African medical journaleurope_pmcdocument de 25 observations

7,9 %The mean HbA1c was 7.9 ± 2.2 % upon arrival at camp.

Cameroundiabète de type 1publié 2016BMC endocrine disorderseurope_pmcdocument de 6 observations

5,9 %Among 413 Cameroonian patients with sickle cell disease, 5.9% had renal failure.

Cameroundrépanocytosepublié 2021Frontiers in geneticseurope_pmcdocument de 5 observations

Selon le PNLP, jusqu’en juin 2002, le paludisme était un problème majeur de santé publique au Cameroun.

Camerounpaludismeobservé juin 2002HAL · Unilimdocument de 98 observations

52,6 %Putative environmental causes accounted for 52.6% of 582 patients with severe hearing loss in Cameroon.

Camerounhearing losspublié 2013European journal of medical geneticseurope_pmcdocument de 8 observations

28 %Among patients with type 2 diabetes (T2D), 28.0% cited fear of hypoglycaemia as a reason for insulin discontinuation.

Cameroundiabète de type 2observé 2016-2017publié 2021Advances in therapyeurope_pmcdocument de 12 observations

925 per_100000In 2010, age-standardised death rates from cardiovascular diseases, chronic kidney disease, and diabetes attributable to the combined effects of high blood pressure, high BMI, high glucose, and high cholesterol surpassed 925 deaths per 100 000 for men in Belarus.

Cameroundiabète (non précisé) · maladie rénale chronique · maladies cardiovasculairesobservé 2010publié 2014The lancet. Diabetes & endocrinologyeurope_pmcdocument de 28 observationsDOI 10.1016/s2213-8587(14)70102-0

32,1 %Among 218 alleles from Cameroonian patients with sickle cell disease (SCD), the c.733C>G SNV was found in 70/218 (32.1%) alleles.

CameroundrépanocytoseHAL · Unilimdocument de 45 observations

19 800 000 peopleDiabetes prevalence in the Africa Region (AFR) is projected to rise from 19.8 million in 2013 to 41.5 million in 2035.

Cameroundiabète (non précisé)observé 2013publié 2014Diabetes research and clinical practiceeurope_pmcdocument de 14 observations

32 %The prevalence of nephropathy varies between 32% and 57% after a mean duration of diabetes of 5–10 years.

Cameroundiabète (non précisé) · nephropathypublié 2003Journal of cardiovascular riskeurope_pmcdocument de 10 observations

1 log10_HIV_RNA_copies_per_mlVersion 1.5 yielded a significant increase in viral load for samples infected with subtypes A and E (greater than 1 log10 HIV RNA copies/ml).

CamerounVIH/sidapublié 1999Journal of Clinical MicrobiologyOpenAlexdocument de 6 observationsDOI 10.1128/jcm.37.1.110-116.1999

66,6 %Among 24 genetically tested Cameroonian patients with congenital adrenal hyperplasia, CYP11 mutation was found in 16 patients (66.6%).

Camerouncongenital adrenal hyperplasiapublié 2022Journal of pediatric endocrinology & metabolism : JPEMeurope_pmcdocument de 6 observations

Total cholesterol was significantly increased with duration of highly active antiretroviral therapy (HAART) in HIV-infected Cameroonians.

CamerounVIH/sidapublié 2013Diabetes & metabolismeurope_pmcdocument de 12 observations

3 patientsRH54 (DAK) low-frequency antigen is predicted in three patients.

CameroundrépanocytoseHAL · Unilimdocument de 45 observations

90 %The probability for non-insulin-dependent ketosis-prone type 2 diabetes to relapse is 90% within 10 years.

Cameroundiabète de type 2observé 10 yearspublié 2004Diabeteseurope_pmcdocument de 8 observationsDOI 10.2337/diabetes.53.3.645

6 %Diabetes hospitalization admissions rates varied across health facilities in Yaounde from 6% (189/3232) in 2000 to 15% (474/3232) in 2008.

Cameroundiabète (non précisé)observé 2000publié 2016BMC public healtheurope_pmcdocument de 12 observationsDOI 10.1186/s12889-016-3090-1

23,8 %The age-standardized prevalence of hypertension alone was 23.8% (95% CI: 20.4 to 27.2) among women in a semi-urban population in Bafoussam, Cameroon.

Camerounhypertension artérielleobservé 2012publié 2014BMC public healtheurope_pmcdocument de 24 observationsDOI 10.1186/1471-2458-14-696

135 cells/mm³The median baseline CD4 count among 169 HIV-1-infected patients was 135 cells/mm³.

CamerounVIH/sidapublié 2010BMC Public HealthOpenAlexdocument de 6 observationsDOI 10.1186/1471-2458-10-105

36 allelesA total of 36 different msp2 alleles were detected in Mfou.

CamerounpaludismeHAL · Unilimdocument de 106 observations

7,22 %Among 194 participants with IgM−/IgG−, 7.22% had positive PCR.

CamerounCOVID-19observé November 2020 to July 2021publié 2023VirusesOpenAlexdocument de 12 observationsDOI 10.3390/v15020407

Chaque ligne mène à son document source. Le nombre indiqué est celui des observations VALIDÉES qu'il porte, jamais celui des observations extraites : les deux diffèrent sur la plupart des documents. L'extrait exact du texte source n'est pas publié, par contrainte de droit d'auteur.